Showing results (101-110 of 157) with videos related to
Sort By:
Pageof 16
Lancet (London, England)|March 15, 1986
Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complexR Yarchoan, R W Klecker, K J Weinhold, et al.Vaccine|December 7, 2007
Safety and immunogenicity of cytotoxic T-lymphocyte poly-epitope, DNA plasmid (EP HIV-1090) vaccine in healthy, human immunodeficiency virus type 1 (HIV-1)-uninfected adultsGeoffrey J Gorse, Lindsey R Baden, Margaret Wecker, et al.Annals of Surgical Oncology|March 5, 2013
Plasma cytokine analysis in patients with advanced extremity melanoma undergoing isolated limb infusionGina Shetty, Georgia M Beasley, Sara Sparks, et al.AIDS (London, England)|August 26, 1998
Safety and immunogenicity of an HLA-based HIV envelope polyvalent synthetic peptide immunogen. DATRI 010 Study Group. Division of AIDS Treatment Research InitiativeJ A Bartlett, S S Wasserman, C B Hicks, et al.American Journal of Respiratory and Critical Care Medicine|September 16, 2015
Polyfunctional T-Cell Signatures to Predict Protection from Cytomegalovirus after Lung TransplantationLaurie D Snyder, Cliburn Chan, Darongsae Kwon, et al.AIDS Research and Human Retroviruses|July 13, 2006
Excellent safety and tolerability of the human immunodeficiency virus type 1 pGA2/JS2 plasmid DNA priming vector vaccine in HIV type 1 uninfected adultsM J Mulligan, N D Russell, C Celum, et al.AIDS Research and Therapy|July 18, 2009
Polychromatic immunophenotypic characterization of T cell profiles among HIV-infected patients experiencing immune reconstitution inflammatory syndrome (IRIS)David M Murdoch, Melinda S Suchard, Willem D F Venter, et al.Science (New York, N.Y.)|December 12, 1986
HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelopeS D Putney, T J Matthews, W G Robey, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1990
Identification of sites within gp41 that serve as targets for antibody-dependent cellular cytotoxicity by using human monoclonal antibodiesD S Tyler, S D Stanley, S Zolla-Pazner, et al.Neurology(R) Neuroimmunology & Neuroinflammation|March 7, 2015
Characterization of B cells in muscle-specific kinase antibody myasthenia gravisJeffrey T Guptill, John S Yi, Donald B Sanders, et al.Pageof 16